Recombinant Anti-DLL4 x Anti-VEGF Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-DLL4 antibody variable domains fused with a scFv from an anti-VEGF antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-DLL4 x Anti-VEGF Bispecific Antibody (Tandem scFv) (BSFV-H315). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS